Cutting Edge Research — Oklahoma City, Oklahoma

Cutting Edge Research is a clinical research site located in Oklahoma City, Oklahoma, United States 73116.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Cutting Edge Research has participated in 9 clinical trials.

Therapeutic areas: Behavioral Symptoms, Autistic Disorder, Osteoarthritis.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Pfizer, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cutting Edge Research?

Cutting Edge Research has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cutting Edge Research conducted?

Cutting Edge Research has 9 clinical trials on record. Their work covers Behavioral Symptoms, Autistic Disorder, Osteoarthritis.

Is Cutting Edge Research accredited by Crixeo Health?

Yes — Cutting Edge Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cutting Edge Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.